NEURONES (NRO.PA) Fundamental Analysis & Valuation

EPA:NRO • FR0004050250

Current stock price

34.65 EUR
+1 (+2.97%)
Last:

This NRO.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NRO.PA Profitability Analysis

1.1 Basic Checks

  • In the past year NRO was profitable.
  • NRO had a positive operating cash flow in the past year.
  • NRO had positive earnings in each of the past 5 years.
  • NRO had a positive operating cash flow in each of the past 5 years.
NRO.PA Yearly Net Income VS EBIT VS OCF VS FCFNRO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.06%, NRO is in the better half of the industry, outperforming 76.06% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 13.65%, NRO is in the better half of the industry, outperforming 64.79% of the companies in the same industry.
  • The Return On Invested Capital of NRO (11.38%) is better than 74.65% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NRO is in line with the industry average of 10.82%.
Industry RankSector Rank
ROA 7.06%
ROE 13.65%
ROIC 11.38%
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
NRO.PA Yearly ROA, ROE, ROICNRO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • NRO has a better Profit Margin (6.09%) than 67.61% of its industry peers.
  • NRO's Profit Margin has been stable in the last couple of years.
  • NRO has a better Operating Margin (8.90%) than 66.20% of its industry peers.
  • In the last couple of years the Operating Margin of NRO has remained more or less at the same level.
  • NRO has a Gross Margin of 99.93%. This is amongst the best in the industry. NRO outperforms 95.77% of its industry peers.
  • NRO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.9%
PM (TTM) 6.09%
GM 99.93%
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
NRO.PA Yearly Profit, Operating, Gross MarginsNRO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. NRO.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NRO is creating some value.
  • NRO has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NRO remains at a similar level compared to 5 years ago.
  • NRO has a better debt/assets ratio than last year.
NRO.PA Yearly Shares OutstandingNRO.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
NRO.PA Yearly Total Debt VS Total AssetsNRO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 4.14 indicates that NRO is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of NRO (4.14) is better than 85.92% of its industry peers.
  • NRO has a debt to FCF ratio of 0.57. This is a very positive value and a sign of high solvency as it would only need 0.57 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.57, NRO belongs to the best of the industry, outperforming 88.73% of the companies in the same industry.
  • NRO has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • NRO's Debt to Equity ratio of 0.08 is amongst the best of the industry. NRO outperforms 84.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.57
Altman-Z 4.14
ROIC/WACC1.46
WACC7.82%
NRO.PA Yearly LT Debt VS Equity VS FCFNRO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.31 indicates that NRO has no problem at all paying its short term obligations.
  • NRO has a better Current ratio (2.31) than 94.37% of its industry peers.
  • A Quick Ratio of 2.31 indicates that NRO has no problem at all paying its short term obligations.
  • NRO has a better Quick ratio (2.31) than 95.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 2.31
NRO.PA Yearly Current Assets VS Current LiabilitesNRO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. NRO.PA Growth Analysis

3.1 Past

  • NRO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.44%.
  • The Earnings Per Share has been growing by 11.23% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 7.39% in the past year.
  • The Revenue has been growing by 9.70% on average over the past years. This is quite good.
EPS 1Y (TTM)4.44%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.04% on average over the next years. This is quite good.
  • Based on estimates for the next years, NRO will show a small growth in Revenue. The Revenue will grow by 5.57% on average per year.
EPS Next Y4.76%
EPS Next 2Y6.9%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue Next Year6.99%
Revenue Next 2Y6.24%
Revenue Next 3Y6.18%
Revenue Next 5Y5.57%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NRO.PA Yearly Revenue VS EstimatesNRO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
NRO.PA Yearly EPS VS EstimatesNRO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

4

4. NRO.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.66, which indicates a correct valuation of NRO.
  • Based on the Price/Earnings ratio, NRO is valued a bit cheaper than 60.56% of the companies in the same industry.
  • NRO is valuated rather cheaply when we compare the Price/Earnings ratio to 25.50, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 14.29, the valuation of NRO can be described as correct.
  • NRO's Price/Forward Earnings is on the same level as the industry average.
  • NRO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.67.
Industry RankSector Rank
PE 16.66
Fwd PE 14.29
NRO.PA Price Earnings VS Forward Price EarningsNRO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NRO is valued cheaper than 90.14% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRO is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 11.66
EV/EBITDA 3.59
NRO.PA Per share dataNRO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NRO does not grow enough to justify the current Price/Earnings ratio.
  • NRO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.5
PEG (5Y)1.48
EPS Next 2Y6.9%
EPS Next 3Y8.74%

7

5. NRO.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.02%, NRO is a good candidate for dividend investing.
  • The stock price of NRO dropped by -21.01% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 2.78, NRO pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, NRO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.02%

5.2 History

  • The dividend of NRO is nicely growing with an annual growth rate of 82.05%!
Dividend Growth(5Y)82.05%
Div Incr Years3
Div Non Decr Years3
NRO.PA Yearly Dividends per shareNRO.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • NRO pays out 57.47% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of NRO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.47%
EPS Next 2Y6.9%
EPS Next 3Y8.74%
NRO.PA Yearly Income VS Free CF VS DividendNRO.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NRO.PA Dividend Payout.NRO.PA Dividend Payout, showing the Payout Ratio.NRO.PA Dividend Payout.PayoutRetained Earnings

NRO.PA Fundamentals: All Metrics, Ratios and Statistics

NEURONES

EPA:NRO (3/25/2026, 10:08:48 AM)

34.65

+1 (+2.97%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-11
Earnings (Next)05-06
Inst Owners12.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap843.03M
Revenue(TTM)832.18M
Net Income(TTM)50.68M
Analysts84
Price Target53.04 (53.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.02%
Yearly Dividend1.2
Dividend Growth(5Y)82.05%
DP57.47%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.76%
EPS NY rev (3m)4.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE 16.66
Fwd PE 14.29
P/S 1.01
P/FCF 11.66
P/OCF 10
P/B 2.27
P/tB 2.73
EV/EBITDA 3.59
EPS(TTM)2.08
EY6%
EPS(NY)2.42
Fwd EY7%
FCF(TTM)2.97
FCFY8.58%
OCF(TTM)3.46
OCFY10%
SpS34.2
BVpS15.26
TBVpS12.69
PEG (NY)3.5
PEG (5Y)1.48
Graham Number26.72
Profitability
Industry RankSector Rank
ROA 7.06%
ROE 13.65%
ROCE 15.78%
ROIC 11.38%
ROICexc 28.14%
ROICexgc 41.95%
OM 8.9%
PM (TTM) 6.09%
GM 99.93%
FCFM 8.69%
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.96%
ROCE(5y)16.06%
ROICexgc growth 3YN/A
ROICexgc growth 5Y9.54%
ROICexc growth 3YN/A
ROICexc growth 5Y6.91%
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
F-Score7
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.57
Debt/EBITDA 0.32
Cap/Depr 66.65%
Cap/Sales 1.44%
Interest Coverage 250
Cash Conversion 91.59%
Profit Quality 142.65%
Current Ratio 2.31
Quick Ratio 2.31
Altman-Z 4.14
F-Score7
WACC7.82%
ROIC/WACC1.46
Cap/Depr(3y)79.83%
Cap/Depr(5y)65.86%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.6%
Profit Quality(3y)115.8%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)4.44%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
EPS Next Y4.76%
EPS Next 2Y6.9%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
Revenue Next Year6.99%
Revenue Next 2Y6.24%
Revenue Next 3Y6.18%
Revenue Next 5Y5.57%
EBIT growth 1Y0.63%
EBIT growth 3Y8.08%
EBIT growth 5Y9.67%
EBIT Next Year22.37%
EBIT Next 3Y14.47%
EBIT Next 5Y11.67%
FCF growth 1Y13.36%
FCF growth 3Y7.7%
FCF growth 5Y6.25%
OCF growth 1Y11.51%
OCF growth 3Y9.37%
OCF growth 5Y6.59%

NEURONES / NRO.PA Fundamental Analysis FAQ

What is the fundamental rating for NRO stock?

ChartMill assigns a fundamental rating of 7 / 10 to NRO.PA.


What is the valuation status for NRO stock?

ChartMill assigns a valuation rating of 4 / 10 to NEURONES (NRO.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for NEURONES?

NEURONES (NRO.PA) has a profitability rating of 7 / 10.


How financially healthy is NEURONES?

The financial health rating of NEURONES (NRO.PA) is 9 / 10.


Can you provide the expected EPS growth for NRO stock?

The Earnings per Share (EPS) of NEURONES (NRO.PA) is expected to grow by 4.76% in the next year.